Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1382 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Allergan Restasis gets Health Canada approval

Allergan said that Restasis is the first prescription eye drop to target the underlying cause of chronic Dry Eye. Allergan claimed that Restasis helps increase the eye’s natural

Sun Moral to take over Dupromise for $360.72m

The acquisition will be partly funded by the proceeds of Sihuan’s IPO and partly from the company’s internally generated funds. Sihuan has been actively looking for opportunities to